Renqiang Yu | Medicine and Dentistry | Best Researcher Award

Dr. Renqiang Yu | Medicine and Dentistry | Best Researcher Award

Deputy Chief PhysicianΒ  at Affiliated Women’s Hospital of Jiangnan University, China

Dr. Renqiang Yu, born on November 3, 1986, is a distinguished Chinese medical professional specializing in pediatrics and clinical research. He currently serves as a Deputy Chief Physician at the Affiliated Women’s Hospital of Jiangnan University. With a robust academic background, Dr. Yu has contributed significantly to the fields of pulmonary angiogenesis, atopic dermatitis, and neonatal health. His recent research focuses on the role of probiotics and short-chain fatty acids in health and disease prevention. He leads multiple nationally funded projects and has published extensively in high-impact journals, covering topics such as gut health, microbiota, and immune modulation. Dr. Yu’s leadership is recognized through his editorial role at Frontiers in Microbiology as a guest associate editor. His innovative research continues to enhance neonatal care and improve the quality of life for children affected by various conditions, positioning him as a leader in his field.

Professional Profile

Education

Dr. Renqiang Yu earned his Doctor of Medicine (M.D.) degree from Nanjing Medical University, one of China’s top medical institutions. His educational journey provided him with a strong foundation in medical sciences, particularly in pediatrics and clinical research. His academic training was marked by a focus on pediatric diseases, neonatology, and immunology, equipping him with the expertise to address critical issues in neonatal health. Dr. Yu’s commitment to advancing medical research is reflected in his continuous engagement with the latest scientific advancements, as he integrates cutting-edge knowledge into his clinical practice. This rigorous academic background has played a crucial role in his ability to lead groundbreaking research and medical initiatives that address public health challenges.

Professional Experience

Dr. Renqiang Yu has a notable career in both clinical and research settings. Currently, he is the Deputy Chief Physician at the Affiliated Women’s Hospital of Jiangnan University, where he leads clinical practices focusing on pediatric and neonatal care. In addition to his clinical duties, Dr. Yu plays an instrumental role in shaping medical research, particularly through his leadership in multiple funded projects. He has served as the principal investigator for projects funded by the National Natural Science Foundation of China, exploring topics such as pulmonary angiogenesis and atopic dermatitis. His work has earned recognition from both national and international scientific communities. Dr. Yu’s diverse professional roles, including his editorial position with Frontiers in Microbiology, reflect his broad impact in the medical field, bridging clinical excellence with groundbreaking research initiatives.

Research Interest

Dr. Renqiang Yu’s research interests focus primarily on pediatrics, neonatal health, and clinical immunology, with a special emphasis on gut microbiota and its impact on immune function. His work explores the mechanisms of pulmonary angiogenesis, particularly in neonates, and the role of probiotics and short-chain fatty acids in disease prevention and immune regulation. Dr. Yu has also delved into the pathophysiology of atopic dermatitis, investigating novel therapeutic approaches to treat this condition. His research contributes significantly to understanding the gut-skin axis and its implications for pediatric diseases. Furthermore, he is interested in the development of innovative treatments for neonatal illnesses, striving to improve patient outcomes through the application of his findings. Through these endeavors, Dr. Yu seeks to bridge the gap between basic science and clinical applications, paving the way for improved pediatric healthcare practices worldwide.

Awards and Honors

Dr. Renqiang Yu has received numerous prestigious awards and honors throughout his career, reflecting his outstanding contributions to the fields of pediatrics and medical research. He was recognized as a key participant in national research initiatives, securing multiple grants from the National Natural Science Foundation of China for his studies on pediatric diseases and immune system modulation. Dr. Yu’s innovative work has earned him recognition from leading academic institutions, and his contributions to advancing neonatal care have been widely acknowledged by his peers. His editorial role in Frontiers in Microbiology further underscores his leadership in the academic community. In addition to these honors, Dr. Yu has been invited to deliver lectures at various international conferences, where he shares his expertise on pediatric immunology and gut health. These accolades affirm his standing as a leading researcher in the field, dedicated to advancing healthcare for children globally.

Publications Top Noted

  • Title: Nrf2 protects against seawater drowning-induced acute lung injury via inhibiting ferroptosis
    Authors: Y Qiu, B Wan, G Liu, Y Wu, D Chen, M Lu, J Chen, R Yu, D Chen, Q Pang
    Journal: Respiratory Research
    Year: 2020
    Citations: 131
  • Title: Inhibition of HMGB1 improves necrotizing enterocolitis by inhibiting NLRP3 via TLR4 and NF‐κB signaling pathways
    Authors: R Yu, S Jiang, Y Tao, P Li, J Yin, Q Zhou
    Journal: Journal of Cellular Physiology
    Year: 2019
    Citations: 109
  • Title: Fatty acid profile and the sn-2 position distribution in triacylglycerols of breast milk during different lactation stages
    Authors: C Qi, J Sun, Y Xia, R Yu, W Wei, J Xiang, Q Jin, H Xiao, X Wang
    Journal: Journal of Agricultural and Food Chemistry
    Year: 2018
    Citations: 102
  • Title: Maternal vitamin D status in the late second trimester and the risk of severe preeclampsia in Southeastern China
    Authors: X Zhao, R Fang, R Yu, D Chen, J Zhao, J Xiao
    Journal: Nutrients
    Year: 2017
    Citations: 99
  • Title: Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice
    Authors: CL Campbell, R Yu, F Li, Q Zhou, D Chen, C Qi, Y Yin, J Sun
    Journal: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
    Year: 2019
    Citations: 79
  • Title: Triacylglycerol composition of breast milk during different lactation stages
    Authors: T Yuan, C Qi, X Dai, Y Xia, C Sun, J Sun, R Yu, Q Zhou, Q Jin, W Wei, …
    Journal: Journal of Agricultural and Food Chemistry
    Year: 2019
    Citations: 68
  • Title: Lactobacillus reuteri improves gut barrier function and affects diurnal variation of the gut microbiota in mice fed a high-fat diet
    Authors: S Li, C Qi, H Zhu, R Yu, C Xie, Y Peng, SW Yin, J Fan, S Zhao, J Sun
    Journal: Food & Function
    Year: 2019
    Citations: 58
  • Title: Evaluating the activity of sodium butyrate to prevent osteoporosis in rats by promoting osteal GSK-3Ξ²/Nrf2 signaling and mitochondrial function
    Authors: X Tang, S Ma, Y Li, Y Sun, K Zhang, Q Zhou, R Yu
    Journal: Journal of Agricultural and Food Chemistry
    Year: 2020
    Citations: 46
  • Title: Short-chain fatty acid (SCFA) and medium-chain fatty acid (MCFA) concentrations in human milk consumed by infants born at different gestational ages and the variations in …
    Authors: X Dai, T Yuan, X Zhang, Q Zhou, H Bi, R Yu, W Wei, X Wang
    Journal: Food & Function
    Year: 2020
    Citations: 44
  • Title: Protective effects of Ξ³-aminobutyric acid against H2O2-induced oxidative stress in RIN-m5F pancreatic cells
    Authors: X Tang, R Yu, Q Zhou, S Jiang, G Le
    Journal: Nutrition & Metabolism
    Year: 2018
    Citations: 40

Qintai Yang | Medicine and Dentistry | Best Researcher Award

Prof. Qintai Yang | Medicine and Dentistry | Best Researcher Award

Associate Professor of The Third Affiliated Hospital of Sun Yat-sen University, China

Prof. Qintai Yang is a distinguished MD, PhD, and Chief Physician, serving as Vice President at the Third Affiliated Hospital of Sun Yat-sen University. πŸ₯ His leadership extends across multiple departments, including Otorhinolaryngology-Head and Neck Surgery, Allergy, and the Naso-Orbital-Maxilla and Skull Base Center. 🌟 Prof. Yang holds a Doctorate in Otorhinolaryngology from Sun Yat-sen University and has furthered his research at the National University of Singapore. πŸŽ“ His impactful work includes leading 22 research projects and publishing over 70 articles in top journals like The New England Journal of Medicine and BMJ. πŸ“š He is also recognized for his contributions with over 10 patents and his role in developing clinical guidelines and popular science articles. πŸ† His innovative research and dedication to medical science have earned him awards such as the Guangdong Province Outstanding Young Medical Talent. 🌟

Professional profile

EducationπŸ“š

Prof. Yang has authored 60 popular science articles and co-authored four specialized monographs. His ability to communicate complex medical information to the public and his peers is essential for promoting health education and fostering a better understanding of medical science. His recognition as a National Excellent Popular Science Author further highlights his excellence in this area.

Professional ExperienceπŸ›οΈ

Professor Qintai Yang, MD, PhD, serves as the Chief Physician and Vice President at the Third Affiliated Hospital of Sun Yat-sen University. He holds several prestigious positions, including Chairman of the Department of Otorhinolaryngology-Head and Neck Surgery, Chairman of the Department of Allergy, and Chairman of the Naso-Orbital-Maxilla and Skull Base Center. His leadership roles highlight his extensive experience and commitment to advancing medical science and patient care.

Research Contributions🌐

Prof. Yang has led 22 research projects and published over 70 scholarly articles, with more than 50 featured in renowned SCI journals such as The New England Journal of Medicine, BMJ, and Allergy. His research output demonstrates a consistent and impactful contribution to medical science, particularly in otorhinolaryngology and allergy. His extensive publication record in high-impact journals signifies the quality and importance of his research.

Awards and RecognitionsπŸ†

Prof. Yang has received several prestigious awards, including the Guangdong Province Outstanding Young Medical Talent and National Excellent Popular Science Author. These accolades reflect his outstanding contributions to medical science and public health education, recognizing his leadership, research excellence, and dedication to advancing his field.

Publications top noted πŸ“œ
  1. πŸ“š Expert consensus on odontogenic maxillary sinusitis multi-disciplinary treatment
    • Authors: Lin, J., Wang, C., Wang, X., … Zhou, X., Zhang, L.
    • Journal: International Journal of Oral Science, 2024
    • Volume/Issue: 16(1), 11
    • Citations: 1
  2. πŸ“˜ Evaluating ChatGPT’s Performance in Answering Questions About Allergic Rhinitis and Chronic Rhinosinusitis
    • Authors: Ye, F., Zhang, H., Luo, X., … Yang, Q., Shi, Z.
    • Journal: Otolaryngology – Head and Neck Surgery (United States), 2024
    • Volume/Issue: 171(2), pp. 571–577
    • Citations: 0
  3. πŸ“– Educational attainment increases the risk of developing allergic rhinitis and (or) eczema: a Mendelian randomization study based on genome-wide association studies in European patients
    • Authors: Zheng, R., Liu, Z., Chen, Z., … Zhang, J., Yang, Q.
    • Journal: Chinese Journal of Preventive Medicine, 2024
    • Volume/Issue: 58(6), pp. 791–798
    • Citations: 0
  4. πŸ“™ Based on CT imaging, surgical approach selection for frontal and ethmoid sinus osteoma
    • Authors: Guo, M., Wu, X., Yuan, T., … Zhang, G., Shi, Z.
    • Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2024
    • Volume/Issue: 38(6), pp. 523–529
    • Citations: 0
  5. πŸ“• Incidence and prognosis of olfactory and gustatory dysfunctions related to SARS-CoV-2 Omicron strain infection in China: A national multicenter survey of 35,566 individuals
    • Authors: Liu, M.-F., Ma, R.-X., Cao, X.-B., … Cheng, L., Liu, J.-F.
    • Journal: World Journal of Otorhinolaryngology – Head and Neck Surgery, 2024
    • Volume/Issue: 10(2), pp. 113–120
    • Citations: 0
  6. πŸ“” Application of image-based artificial intelligence in rhinology
    • Authors: Chao, W.H., Luo, X., Liang, G.X., … Shi, Z.H., Yang, Q.T.
    • Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2024
    • Volume/Issue: 59(3), pp. 277–283
    • Citations: 0
  7. πŸ“— Xiaoqinglong decoction improves allergic rhinitis by inhibiting NLRP3-mediated pyroptosis in BALB/C mice
    • Authors: Wang, R., Wang, Y., Yang, Q., … Ruan, Y., Zhou, M.
    • Journal: Journal of Ethnopharmacology, 2024
    • Volume: 321, 117490
    • Citations: 2
  8. πŸ““ Body mass index’s effect on CRSwNP extends to pathological endotype and recurrence
    • Authors: Chen, W., Bai, Y., Fang, P., … Yang, Q., Zhang, Y.
    • Journal: Rhinology, 2024
    • Volume/Issue: 62(3), pp. 370–382
    • Citations: 0
  9. πŸ“’ Characteristics and therapeutic strategies of Potts puffy tumor
    • Authors: Deng, H., Chen, Z., Wu, X., Yang, Q.
    • Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2024
    • Volume/Issue: 38(1)
    • Citations: 0
  10. πŸ“™ Preliminary insights into the practice of hypoallergenic home visiting program
    • Authors: Zhang, H., Zhou, M., Zhou, Q., … Chen, Z., Yang, Q.
    • Journal: Chinese Journal of Preventive Medicine, 2023
    • Volume/Issue: 57(12), pp. 1957–1963
    • Citations: 0

Shi Xiaoli | Medicine and Dentistry | Best Researcher Award

Dr. Shi Xiaoli | Medicine and Dentistry | Best Researcher Award

Attending Physician of Jiangsu Provincial People’s Hospital, China

Dr. Shi Xiaoli, originally from Jiangsu, China, is a distinguished scholar in the field of surgery. 🌟 With a Ph.D. from Southeast University, in collaboration with Nanjing Medical University, Dr. Shi has demonstrated exceptional expertise and dedication in his field. πŸŽ“ His academic journey includes a master’s degree in surgery from Nanjing Medical University, under the mentorship of esteemed advisors Wang Xuehao, Li Xiangcheng, and Yu Yue. πŸ‘¨β€πŸ«πŸ‘©β€πŸ« Currently residing in Gulou District, Nanjing, Dr. Shi holds professional certifications and has completed standard training. πŸ πŸ‘¨β€βš•οΈ His contributions to the medical field are marked by a commitment to advancing surgical practices and knowledge.

Professional profile

EducationπŸ“š

Dr. Shi Xiaoli’s educational journey is marked by significant achievements in the field of surgery. πŸŽ“ He pursued his doctoral studies at Southeast University, in collaboration with Nanjing Medical University, where he earned his Ph.D. in Surgery from September 2021 to July 2024. πŸ“œ Prior to this, he completed his Master’s degree in Surgery at Nanjing Medical University from September 2018 to July 2021. πŸ… Dr. Shi’s academic background reflects a deep commitment to advancing his expertise and contributing to the field of medical science.

Professional ExperienceπŸ›οΈ

Dr. Shi Xiaoli has accumulated extensive professional experience in the field of surgery. πŸ’Ό His career is distinguished by significant contributions to medical practice and research, underscoring his expertise and dedication. πŸ₯ With a robust foundation in clinical and academic settings, Dr. Shi has honed his skills through rigorous training and hands-on experience, establishing himself as a knowledgeable and proficient surgeon. 🩺 His professional journey reflects a strong commitment to enhancing patient care and advancing surgical techniques. 🌟

Research Interest🌐

Dr. Shi Xiaoli is deeply engaged in research within the field of surgery, focusing on advancing surgical techniques and improving patient outcomes. πŸ”¬ His interests span innovative surgical methods, disease treatment advancements, and the integration of cutting-edge technologies in medical practice. πŸ₯πŸ’‘ Driven by a commitment to enhancing surgical precision and efficacy, Dr. Shi explores new approaches to surgery and strives to contribute valuable insights to the medical community. πŸ“ŠπŸ” His research aims to address current challenges in the field and push the boundaries of surgical science. 🌟

Awards and HonorsπŸ†

Dr. Shi Xiaoli has received several prestigious awards and honors, reflecting his excellence and dedication in the field of surgery. πŸ† His achievements include notable recognitions for outstanding research and contributions to medical science. 🌟 Among his accolades are esteemed awards from professional medical associations and institutions, highlighting his impact and leadership in the field. πŸ…βœ¨ These honors not only celebrate his academic and clinical accomplishments but also underscore his commitment to advancing surgical practices and patient care. πŸ₯πŸ‘

Research skillπŸ”¬

Dr. Shi Xiaoli possesses a robust set of research skills that underscore his expertise in the field of surgery. πŸ”¬ He excels in designing and conducting rigorous studies, utilizing advanced methodologies to explore surgical techniques and patient care innovations. πŸ“Š With a keen eye for detail and a commitment to precision, Dr. Shi employs sophisticated analytical tools and technologies to derive meaningful insights from his research. πŸ’‘ His ability to critically evaluate data and integrate findings into practical applications reflects his deep understanding of both clinical and academic aspects of surgery. πŸ₯πŸ” His research skills contribute significantly to advancing medical science and improving surgical outcomes. πŸŒŸπŸ“ˆ

AchievementsπŸ…
  • πŸŽ“ Ph.D. in Surgery from Southeast University (Jointly trained with Nanjing Medical University)
  • πŸ… Master’s Degree in Surgery from Nanjing Medical University
  • 🩺 Professional Certification in Surgery
  • πŸ‘¨β€βš•οΈ Completed Standard Training in clinical practice
  • 🌟 Significant Contributions to surgical techniques and patient care innovations
  • πŸ”¬ Advanced Research in surgical methods and technologies
ProjectsπŸ› οΈ
  • πŸ₯ Innovative Surgical Techniques: Development and implementation of new methods to improve surgical outcomes.
  • πŸ”¬ Advanced Research Studies: Exploration of cutting-edge technologies and approaches in surgery.
  • πŸ“Š Patient Care Enhancements: Projects focused on optimizing patient care through improved surgical practices.
  • πŸ’‘ Technology Integration: Incorporation of advanced technologies into surgical procedures and treatment plans.
  • πŸ§ͺ Clinical Trials: Conducting trials to assess the efficacy and safety of new surgical techniques and treatments.
PublicationπŸ“œ
  • RAC1^high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis
    • πŸ“ Authors: Shi, X., Chen, W., Yin, Y., Yu, Y., Wang, X.
    • πŸ“… Year: 2024
    • πŸ—žοΈ Journal: Cancer Letters
    • πŸ“ˆ Citations: 0
  • Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma
    • πŸ“ Authors: Shi, X., Shi, D., Yin, Y., Yu, Y., Wang, X.
    • πŸ“… Year: 2024
    • πŸ—žοΈ Journal: Cellular Signalling
    • πŸ“ˆ Citations: 0
  • MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex
    • πŸ“ Authors: Jiang, W., Yang, X., Shi, K., Li, C., Li, X.
    • πŸ“… Year: 2023
    • πŸ—žοΈ Journal: Oncogene
    • πŸ“ˆ Citations: 3
  • Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners
    • πŸ“ Authors: Li, Q., Zhang, L., Yang, Q., Zhang, P., Wang, X.
    • πŸ“… Year: 2023
    • πŸ—žοΈ Journal: Cell Metabolism
    • πŸ“ˆ Citations: 10
  • KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-ΞΊB pathway in cholangiocarcinoma
    • πŸ“ Authors: Jiang, W., Wang, J., Yang, X., Li, C., Li, X.
    • πŸ“… Year: 2023
    • πŸ—žοΈ Journal: Oncogene
    • πŸ“ˆ Citations: 8
  • Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway
    • πŸ“ Authors: Ni, Q., Zhang, H., Shi, X., Li, X.
    • πŸ“… Year: 2023
    • πŸ—žοΈ Journal: Cancer Gene Therapy
    • πŸ“ˆ Citations: 13
  • Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner
    • πŸ“ Authors: Jiang, W., Shi, X., Sun, L., Li, C., Li, X.
    • πŸ“… Year: 2023
    • πŸ—žοΈ Journal: International Journal of Biological Sciences
    • πŸ“ˆ Citations: 1
  • NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1
    • πŸ“ Authors: Shan, J., Jiang, W., Chang, J., Li, C., Li, X.
    • πŸ“… Year: 2023
    • πŸ—žοΈ Journal: International Journal of Biological Sciences
    • πŸ“ˆ Citations: 6
  • CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ΞΆ
    • πŸ“ Authors: Hao, X., Zhang, Y., Shi, X., Tang, W., Wang, X.
    • πŸ“… Year: 2022
    • πŸ—žοΈ Journal: Journal of Experimental and Clinical Cancer Research
    • πŸ“ˆ Citations: 32
  • ROBO1 p.E280 Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal*
    • πŸ“ Authors: Zhou, T., Zhang, Y., Chen, Y., Li, C., Li, X.
    • πŸ“… Year: 2022
    • πŸ—žοΈ Journal: Frontiers in Oncology
    • πŸ“ˆ Citations: 2